DD240011A5 - Verfahren zur herstellung eines neuen substituierten amid-derivates - Google Patents
Verfahren zur herstellung eines neuen substituierten amid-derivates Download PDFInfo
- Publication number
- DD240011A5 DD240011A5 DD85278694A DD27869485A DD240011A5 DD 240011 A5 DD240011 A5 DD 240011A5 DD 85278694 A DD85278694 A DD 85278694A DD 27869485 A DD27869485 A DD 27869485A DD 240011 A5 DD240011 A5 DD 240011A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- radical
- amino
- naphthyridine
- temperature
- kpa
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Materials For Medical Uses (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Cephalosporin Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8411442A FR2567887B1 (fr) | 1984-07-19 | 1984-07-19 | Nouveaux amides substitues, leur preparation et les medicaments qui les contiennent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DD240011A5 true DD240011A5 (de) | 1986-10-15 |
Family
ID=9306273
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD85278694A DD240011A5 (de) | 1984-07-19 | 1985-07-17 | Verfahren zur herstellung eines neuen substituierten amid-derivates |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US4642308A (es) |
| EP (1) | EP0172083B1 (es) |
| JP (1) | JPS6163656A (es) |
| KR (1) | KR860001100A (es) |
| AT (1) | ATE33652T1 (es) |
| AU (1) | AU572672B2 (es) |
| CA (1) | CA1224787A (es) |
| CS (1) | CS253730B2 (es) |
| DD (1) | DD240011A5 (es) |
| DE (1) | DE3562250D1 (es) |
| DK (1) | DK327285A (es) |
| ES (1) | ES8604584A1 (es) |
| FI (1) | FI79313C (es) |
| FR (1) | FR2567887B1 (es) |
| GR (1) | GR851774B (es) |
| HU (1) | HU199802B (es) |
| IL (1) | IL75817A (es) |
| MA (1) | MA20487A1 (es) |
| NO (1) | NO161673C (es) |
| NZ (1) | NZ212764A (es) |
| OA (1) | OA08069A (es) |
| PH (1) | PH21301A (es) |
| PL (1) | PL145331B1 (es) |
| PT (1) | PT80840B (es) |
| SU (1) | SU1417797A3 (es) |
| YU (1) | YU118785A (es) |
| ZA (1) | ZA855409B (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3662788D1 (en) * | 1985-07-11 | 1989-05-18 | Rhone Poulenc Sante | Substituted amides, their preparation and compositions containing them |
| FR2592882B2 (fr) * | 1986-01-16 | 1988-03-11 | Rhone Poulenc Sante | Nouveaux amides substitues, leur preparation et les medicaments qui les contiennent |
| US4753941A (en) * | 1986-01-16 | 1988-06-28 | Rhone-Poulenc Sante | Amides based on certain 1,8-naphtyridine-2-amines useful as anxiolytics |
| US5197518A (en) * | 1991-06-27 | 1993-03-30 | Double Containment Systems | Centering support assembly for double containment pipe systems |
| GB9711257D0 (en) * | 1997-05-30 | 1997-07-30 | Smithkline Beecham Plc | Novel compounds |
| EP1155017B1 (en) * | 1999-02-22 | 2003-01-15 | Shire Biochem Inc. | [1,8] naphthyridine derivatives having antiviral activity |
| JP4667384B2 (ja) * | 2003-10-07 | 2011-04-13 | レノビス， インコーポレイテッド | イオンチャネルリガンドとしてのアミド誘導体および薬学的組成物、ならびにこれらを使用する方法 |
| US7576099B2 (en) | 2005-02-28 | 2009-08-18 | Renovis, Inc. | Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| US20080300243A1 (en) * | 2005-02-28 | 2008-12-04 | Kelly Michael G | Amide Derivatives as Ion-Channel Ligands and Pharmaceutical Compositions and Methods of Using the Same |
| WO2013090725A1 (en) * | 2011-12-15 | 2013-06-20 | Philadelphia Health & Education Corporation | NOVEL PI3K p110 INHIBITORS AND METHODS OF USE THEREOF |
| CN105646487B (zh) * | 2016-03-15 | 2017-12-05 | 红河学院 | 一类溴代1,8‑萘啶衍生物及其制备方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB661515A (en) * | 1948-08-31 | 1951-11-21 | Cilag Ltd | Process for the production of naphthyridine derivatives |
| FR1006725A (fr) * | 1948-08-31 | 1952-04-28 | Cilag Spa | Nouveaux dérivés de la naphtyridine et procédé pour leur préparation |
| US3389142A (en) * | 1966-09-29 | 1968-06-18 | Bristol Myers Co | Esters of 2-substituted 1, 2-dihydroquinoline-nu-carboxylic acids and thione acids |
| US3576809A (en) * | 1968-05-06 | 1971-04-27 | Miles Lab | 2-substituted derivatives of 6-methoxyquinoline |
| US3624097A (en) * | 1969-07-22 | 1971-11-30 | Warner Lambert Co | N-pyridine 5-aminooxazoles |
| US4466965A (en) * | 1982-07-26 | 1984-08-21 | American Hospital Supply Corporation | Phthalazine compounds, compositions and use |
-
1984
- 1984-07-19 FR FR8411442A patent/FR2567887B1/fr not_active Expired
-
1985
- 1985-06-28 CA CA000485859A patent/CA1224787A/fr not_active Expired
- 1985-07-15 IL IL75817A patent/IL75817A/xx unknown
- 1985-07-16 MA MA20712A patent/MA20487A1/fr unknown
- 1985-07-17 NZ NZ212764A patent/NZ212764A/en unknown
- 1985-07-17 DD DD85278694A patent/DD240011A5/de unknown
- 1985-07-17 GR GR851774A patent/GR851774B/el unknown
- 1985-07-17 PL PL1985254570A patent/PL145331B1/pl unknown
- 1985-07-17 AU AU45090/85A patent/AU572672B2/en not_active Ceased
- 1985-07-17 ZA ZA855409A patent/ZA855409B/xx unknown
- 1985-07-17 US US06/755,896 patent/US4642308A/en not_active Expired - Fee Related
- 1985-07-18 ES ES545336A patent/ES8604584A1/es not_active Expired
- 1985-07-18 KR KR1019850005134A patent/KR860001100A/ko not_active Application Discontinuation
- 1985-07-18 FI FI852821A patent/FI79313C/fi not_active IP Right Cessation
- 1985-07-18 DK DK327285A patent/DK327285A/da not_active Application Discontinuation
- 1985-07-18 CS CS855344A patent/CS253730B2/cs unknown
- 1985-07-18 DE DE8585401480T patent/DE3562250D1/de not_active Expired
- 1985-07-18 NO NO852877A patent/NO161673C/no unknown
- 1985-07-18 AT AT85401480T patent/ATE33652T1/de not_active IP Right Cessation
- 1985-07-18 HU HU852764A patent/HU199802B/hu not_active IP Right Cessation
- 1985-07-18 PH PH32541A patent/PH21301A/en unknown
- 1985-07-18 EP EP85401480A patent/EP0172083B1/fr not_active Expired
- 1985-07-18 SU SU853923698A patent/SU1417797A3/ru active
- 1985-07-19 OA OA58648A patent/OA08069A/xx unknown
- 1985-07-19 YU YU01187/85A patent/YU118785A/xx unknown
- 1985-07-19 PT PT80840A patent/PT80840B/pt not_active IP Right Cessation
- 1985-07-19 JP JP60158504A patent/JPS6163656A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69726876T2 (de) | Anthranilsäure-derivate als modulatoren der multidrug resistenz. | |
| DE60124577T2 (de) | Aza- und polyaza-naphthalenylcarbonsäureamide als hiv-integrase-hemmer | |
| EP0270947B1 (de) | Substituierte basische 2-Aminotetraline | |
| DE60215699T2 (de) | Quinolinone als prostaglandin rezeptor liganden | |
| DE60025856T2 (de) | Neue Pseudoerythromycin Derivate | |
| WO1999055696A1 (de) | Neue hydroxyindole, deren verwendung als inhibitoren der phosphodiesterase 4 und verfahren zu deren herstellung | |
| EP0509398B1 (de) | Chinoxaline, Verfahren zu ihrer Herstellung und ihre Verwendung | |
| EP2508521A2 (de) | Verfahren zur Herstellung von Aminocrotonylverbindungen | |
| DE3331808A1 (de) | Carbostyrilderivate, verfahren zu deren herstellung und arzneimittel, welche diese enthalten | |
| DE602004005960T2 (de) | Heteroaryl-substituierte pyrrolä2, 3- büpyridin-derivate als crf-rezeptor-antagonisten | |
| DD240011A5 (de) | Verfahren zur herstellung eines neuen substituierten amid-derivates | |
| EP0062001A2 (de) | Acyl-chinolinonderivate, Verfahren zu ihrer Herstellung, diese enthaltende pharmazeutische Präparate und ihre Verwendung | |
| EP0657166A1 (de) | Kombinationspräparate, enthaltend ein Chinoxalin und ein Nukleosid | |
| DD145104A5 (de) | Verfahren zur herstellung von polyalkoxyphenylpyrrolidone | |
| DE3216843C2 (de) | 3-Thiomethyl-pyridin-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
| DE3049959C2 (es) | ||
| DD216014A5 (de) | Verfahren zur herstellung von verbindungen mit einem heterocyclischen distickstoffkern | |
| DE2632118C3 (de) | Apovincaminolester und Verfahren zu deren Herstellung und Arzneimittel | |
| CH642967A5 (de) | Neue pyrimidoisochinolin-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate. | |
| EP0224159B1 (de) | Neue basisch substituierte Pyridinverbindungen, Verfahren zu ihrer Herstellung, die sie enthaltenden Arzneimittel und ihre Verwendung | |
| DE19818964A1 (de) | Neue Hydroxyindole, deren Verwendung als Inhibitoren der Phospodiesterase 4 und Verfahren zu deren Herstellung | |
| DE2733867B2 (de) | Oleandomycinderivate und diese Verbindungen enthaltende antibakterielle Mittel | |
| DE69917243T2 (de) | Zimtsäure-Derivate mit Zelladhäsion modulierender Aktivität | |
| CH620685A5 (es) | ||
| DE2913295A1 (de) | 4-oxo-4h-pyrido eckige klammer auf 1,2-a eckige klammer zu pyrimidin-3-n- (1h-tetrazol-5-yl)carboxamide, verfahren zu deren herstellung und pharmazeutisches mittel |